ARA‐AMP in chronic HBV hepatitis: Follow‐up too short or too long?
Albert J. Czaja – 1 May 1986 – A randomised controlled trial was conducted in 29 HBV carriers who had been HBs and HBe antigen positive for more than six months. Fifteen patients were treated with ARA‐AMP 10 mg/kg/ day given as intramuscular injections 12 hours apart for five days followed by 5 mg/kg/day for 23 days. The 14 controls received no treatment. Serum HBV‐DNA polymerase, and HBV‐DNA decreased in all patients during therapy. Six treated patients lost serum HBV‐DNA polymerase, HBV‐DNA and HBeAg, HBsAg concentrations decreased, and five developed anti‐HBe.